Doshi Dipal — SEC insider filings

SEC reporting owner CIK 1613084. 43 insider filings on record with FilingPulse; latest filed 2026-09-03.

Transaction summary — filings shown

Covers all 43 filings on record, filed 2021-11-01 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Entrada Therapeutics, Inc. (TRDA)CEO, Director41—49 legs · 86,992 sh · $1,387,75234
Azenta, Inc. (AZTA)Director2——2

Insider filings — Doshi Dipal

FiledFormIssuerReported transactionsSource
2026-09-034Entrada Therapeutics, Inc. (TRDA)Tax withholding (F): 8,724 @ $7.14EDGAR
2026-03-034Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 139,400 @ $0 · Tax withholding (F): 9,869 @ $11.66 · Tax withholding (F): 19,181 @ $11.76 · Grant/award (A): 208,000 (derivative) @ $0EDGAR
2026-02-064Azenta, Inc. (AZTA)Grant/award (A): 5,663 @ $27.85EDGAR
2025-09-044Entrada Therapeutics, Inc. (TRDA)Tax withholding (F): 8,723 @ $5.43EDGAR
2025-03-044Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 116,200 @ $0 · Tax withholding (F): 17,566 @ $11.68 · Grant/award (A): 173,400 (derivative) @ $0EDGAR
2025-02-114Azenta, Inc. (AZTA)Grant/award (A): 4,040 @ $52.32EDGAR
2024-09-054Entrada Therapeutics, Inc. (TRDA)Tax withholding (F): 2,328 @ $15.76 · Tax withholding (F): 752 @ $16.93 · Tax withholding (F): 72 @ $17.70 · Tax withholding (F): 4,744 @ $15.42 · Tax withholding (F): 826 @ $15.13EDGAR
2024-07-164Entrada Therapeutics, Inc. (TRDA)Sale (S): 300 @ $18 · Sale (S): 1,600 @ $17.81EDGAR
2024-06-144Entrada Therapeutics, Inc. (TRDA)Sale (S): 1,000 @ $16.17EDGAR
2024-05-204Entrada Therapeutics, Inc. (TRDA)Sale (S): 1,800 @ $15 · Sale (S): 1,200 @ $15.11EDGAR
2024-03-054Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 104,700 @ $0 · Tax withholding (F): 1,164 @ $12.42 · Tax withholding (F): 1,391 @ $13.37 · Tax withholding (F): 5,049 @ $12.28 · Grant/award (A): 158,500 (derivative) @ $0EDGAR
2024-02-204Entrada Therapeutics, Inc. (TRDA)Sale (S): 1,000 @ $15EDGAR
2024-01-184Entrada Therapeutics, Inc. (TRDA)Sale (S): 1,000 @ $15.99EDGAR
2023-12-224Entrada Therapeutics, Inc. (TRDA)Sale (S): 1,000 @ $15EDGAR
2023-11-134Entrada Therapeutics, Inc. (TRDA)Sale (S): 1,000 @ $16.23EDGAR
2023-10-194Entrada Therapeutics, Inc. (TRDA)Sale (S): 1,000 @ $15EDGAR
2023-09-154Entrada Therapeutics, Inc. (TRDA)Sale (S): 1,000 @ $15EDGAR
2023-09-064Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 49,650 @ $0 · Tax withholding (F): 1,440 @ $14.46 · Grant/award (A): 75,250 (derivative) @ $0EDGAR
2023-08-164Entrada Therapeutics, Inc. (TRDA)Sale (S): 1,000 @ $15.67EDGAR
2023-05-014Entrada Therapeutics, Inc. (TRDA)Sale (S): 2,000 @ $13.71EDGAR
2023-04-194/AEntrada Therapeutics, Inc. (TRDA)Grant/award (A): 49,650 @ $0 · Grant/award (A): 75,250 (derivative) @ $0EDGAR
2023-04-194Entrada Therapeutics, Inc. (TRDA)Sale (S): 2,092 @ $18.01EDGAR
2023-03-294Entrada Therapeutics, Inc. (TRDA)Sale (S): 1,800 @ $14.63 · Sale (S): 200 @ $15.51EDGAR
2023-03-034Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 99,300 @ $0 · Tax withholding (F): 3,324 @ $11.60 · Grant/award (A): 150,500 (derivative) @ $0EDGAR
2023-03-024Entrada Therapeutics, Inc. (TRDA)Sale (S): 2,000 @ $12EDGAR
2023-01-304Entrada Therapeutics, Inc. (TRDA)Sale (S): 2,000 @ $12.00EDGAR
2023-01-104Entrada Therapeutics, Inc. (TRDA)Sale (S): 2,410 @ $15.02EDGAR
2022-12-294Entrada Therapeutics, Inc. (TRDA)Sale (S): 600 @ $14.80 · Sale (S): 9,069 @ $15.04 · Sale (S): 4,521 @ $15.01 · Sale (S): 400 @ $15.01EDGAR
2022-11-304Entrada Therapeutics, Inc. (TRDA)Sale (S): 2,000 @ $13.91EDGAR
2022-10-274Entrada Therapeutics, Inc. (TRDA)Sale (S): 3,055 @ $20.01 · Sale (S): 7,506 @ $20.76 · Sale (S): 1,500 @ $21.50 · Sale (S): 2,000 @ $21.66EDGAR
2022-10-244Entrada Therapeutics, Inc. (TRDA)Sale (S): 811 @ $18.01 · Sale (S): 2,786 @ $18.28 · Sale (S): 1,101 @ $18.90 · Sale (S): 1,241 @ $19.65EDGAR
2022-09-284Entrada Therapeutics, Inc. (TRDA)Sale (S): 2,795 @ $15.22 · Sale (S): 288 @ $16.30 · Sale (S): 3,453 @ $15.04 · Sale (S): 966 @ $15.82 · Sale (S): 3,085 @ $15.23EDGAR
2022-09-234Entrada Therapeutics, Inc. (TRDA)Sale (S): 3,402 @ $15.12 · Sale (S): 1,023 @ $15.07EDGAR
2022-09-194Entrada Therapeutics, Inc. (TRDA)Sale (S): 200 @ $15.04EDGAR
2022-09-124Entrada Therapeutics, Inc. (TRDA)Sale (S): 1,100 @ $15.16 · Sale (S): 688 @ $15.07EDGAR
2022-09-064Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 15,125 @ $0EDGAR
2022-08-314Entrada Therapeutics, Inc. (TRDA)Sale (S): 1,109 @ $12.56 · Sale (S): 505 @ $13.51 · Sale (S): 25 @ $14 · Sale (S): 190 @ $12 · Sale (S): 171 @ $12EDGAR
2022-07-294Entrada Therapeutics, Inc. (TRDA)Sale (S): 2,000 @ $12EDGAR
2022-07-064Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 90,750 (derivative) @ $0EDGAR
2022-06-294Entrada Therapeutics, Inc. (TRDA)Sale (S): 4,000 @ $12EDGAR
2022-03-034Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 30,250 @ $0 · Grant/award (A): 181,500 (derivative) @ $0EDGAR
2022-01-184Entrada Therapeutics, Inc. (TRDA)Option exercise (M): 10,000 @ $1.74 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-11-014Entrada Therapeutics, Inc. (TRDA)Grant/award (A): 184,821 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-10-27 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1613084 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs